Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/26620
Title: Advancing a causal role of type 2 diabetes and its components in developing macro- and microvascular complications via genetic studies
Authors: Ahmed, A
Sattar, N
Yaghootkar, H
Keywords: genetics of type 2 diabetes;macrovascular disease;mendelian randomization;microvascular disease
Issue Date: 30-Oct-2022
Publisher: John Wiley & Sons Ltd on behalf of Diabetes UK
Citation: Ahmed, A., Sattar, N. and Yaghootkar, H. (2022) 'Advancing a causal role of type 2 diabetes and its components in developing macro- and microvascular complications via genetic studies', Diabetic Medicine, 39 (12), e14982, pp. 1 - 15. doi: 10.1111/dme.14982.
Abstract: Copyright © 2022 The Authors. The role of diabetes in developing microvascular and macrovascular complications has been subject to extensive research. Despite multiple observational and genetic studies, the causal inference of diabetes (and associated risk factors) on those complications remains incomplete. In this review, we focused on type 2 diabetes, as the major form of diabetes, and investigated the evidence of causality provided by observational and genetic studies. We found that genetic studies based on Mendelian randomization provided consistent evidence of causal inference of type 2 diabetes on macrovascular complications; however, the evidence for causal inference on microvascular complications has been somewhat limited. We also noted high BMI could be causal for several diabetes complications, notable given high BMI is commonly upstream of type 2 diabetes and the recent calls to target weight loss more aggressively. We emphasize the need for further studies to identify type 2 diabetes components that mostly drive the risk of those complications. Even so, the genetic evidence summarized broadly concurs with the need for a multifactorial risk reduction approach in type 2 diabetes, including addressing excess adiposity.
Description: Data Availability Statement: I confirm that my Data Availability Statement (pasted below) complies with the Expects Data Policy. The data that support the findings of this study are available in the supplementary material of this article.
URI: https://bura.brunel.ac.uk/handle/2438/26620
DOI: https://doi.org/10.1111/dme.14982
ISSN: 0742-3071
Other Identifiers: ORCID iDs: Naveed Sattar https://orcid.org/0000-0002-1604-2593; Hanieh Yaghootkar https://orcid.org/0000-0001-9672-9477.
e14982
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.2.14 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons